13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$2.04T
−22% on the quarter before
Positions
5,013
216 new · 235 sold out
Top 10
17.7%
of the value
Est. gain
−$550.61B
on stocks held all quarter
Est. return
−21.7%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 28% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrCALL~$1.67BAdded · 0.4% → 0.4%+6,460,600 underlying
- Vanguard Index Fds~$1.53BAdded · 0.0% → 0.1%+6,455,033 shares
- Trane Technologies Plc~$1.42BNew · 0.0% → 0.1%+17,198,492 shares
- Ishares Tr~$1.09BAdded · 0.4% → 0.5%+23,107,666 shares
- Prologis~$931.0MAdded · 0.2% → 0.3%+11,584,385 shares
- Essential Utils Inc~$897.0MNew · 0.0% → 0.0%+22,039,682 shares
- SPDR Gold Trust~$798.1MAdded · 0.0% → 0.1%+5,390,754 shares
- Centene Corp Del~$777.0MAdded · 0.1% → 0.1%+13,078,726 shares
- Digital Realty~$734.2MAdded · 0.1% → 0.2%+5,285,137 shares
- Adobe~$706.4MAdded · 0.4% → 0.6%+2,219,627 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ingersoll-Rand Plc~$2.26BSold out · 0.1% → 0.0%−16,979,006 shares
- Liberty Ppty Tr~$1.24BSold out · 0.0% → 0.0%−20,690,611 shares
- SPDR S&P 500 ETF TrPUT~$1.19BCut · 0.1% → 0.0%−4,622,400 underlying
- Wellcare Health Plans Inc~$1.19BSold out · 0.0% → 0.0%−3,603,430 shares
- Aqua America Inc~$1.07BSold out · 0.0% → 0.0%−22,835,834 shares
- Axa Equitable Hldgs Inc~$1.05BSold out · 0.0% → 0.0%−42,212,096 shares
- Select Sector SPDR TrCALL~$1.03BSold out · 0.0% → 0.0%−8,222,600 underlying
- Medicines Co~$1.03BSold out · 0.0% → 0.0%−12,101,435 shares
- Apple~$784.8MCut · 3.1% → 3.4%−3,086,069 shares
- AT&T~$560.8MCut · 0.8% → 0.7%−19,237,972 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.5% · price +0.0% | 4.0% | $81.63B | +$5.2M | ||||||||
| AppleCOM · shares −1.1% · price −13.4% | 3.4% | $69.85B | −$10.81B | ||||||||
| AmazonCOM · shares +1.2% · price +5.5% | 2.6% | $52.69B | +$2.72B | ||||||||
| MetaCL A · shares +1.2% · price −18.7% | 1.3% | $26.56B | −$6.05B | ||||||||
| Johnson & JohnsonCOM · shares −0.2% · price −10.1% | 1.2% | $25.25B | −$2.84B | ||||||||
| AlphabetCAP STK CL C · shares +1.5% · price −13.0% | 1.2% | $23.56B | −$3.48B | ||||||||
| AlphabetCAP STK CL A · shares +2.1% · price −13.2% | 1.1% | $23.36B | −$3.49B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −0.2% · price −19.3% | 0.98% | $20.09B | −$4.80B | ||||||||
| Visa Inc.COM CL A · shares −1.4% · price −14.3% | 0.97% | $19.89B | −$3.31B | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.1% · price −35.4% | 0.90% | $18.40B | −$10.09B | ||||||||
| Procter & Gamble CoCOM · shares −2.2% · price −11.9% | 0.89% | $18.10B | −$2.45B | ||||||||
| Unitedhealth Group IncCOM · shares +2.3% · price −15.2% | 0.85% | $17.39B | −$3.04B | ||||||||
| AlibabaSPONSORED ADS · shares −0.9% · price −8.3% | 0.84% | $17.15B | −$1.55B | ||||||||
| IntelCOM · shares +2.9% · price −9.6% | 0.82% | $16.85B | −$1.73B | ||||||||
| Verizon Communications IncCOM · shares −1.7% · price −12.5% | 0.82% | $16.75B | −$2.39B | ||||||||
| MastercardCL A · shares +0.7% · price −19.1% | 0.79% | $16.16B | −$3.79B | ||||||||
| Merck & Co. IncCOM · shares +2.9% · price −15.4% | 0.74% | $15.11B | −$2.67B | ||||||||
| Ishares TrCORE S&P500 ETF · shares +3.7% · price −20.1% | 0.71% | $14.41B | −$3.49B | ||||||||
| AT&TCOM · shares −3.8% · price −25.4% | 0.70% | $14.39B | −$4.90B | ||||||||
| Pfizer IncCOM · shares −0.5% · price −16.7% | 0.68% | $13.84B | −$2.77B | ||||||||
| Home Depot IncCOM · shares −0.3% · price −14.5% | 0.66% | $13.40B | −$2.27B | ||||||||
| Pepsico IncCOM · shares +2.6% · price −12.1% | 0.64% | $13.10B | −$1.76B | ||||||||
| CiscoCOM · shares +1.9% · price −18.0% | 0.62% | $12.70B | −$2.74B | ||||||||
| Coca Cola CoCOM · shares +1.9% · price −20.1% | 0.60% | $12.36B | −$3.04B | ||||||||
| AdobeCOM · shares +6.5% · price −3.5% | 0.57% | $11.60B | −$396.0M | ||||||||
| Total · 5,013 positions | 100% | $2.04T | −$550.61B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 4,568 stocks held throughout, down $550.61B (−21.7%).
- Amazon+$2.72B+6%
- Netflix+$1.41B+16%
- Nvidia+$1.14B+12%
- Gilead Sciences Inc+$989.9M+15%
- Tesla+$708.6M+25%
- Wells Fargo Co New−$6.89B−47%
- Bk Of America Corp−$7.53B−40%
- Exxon Mobil Corp−$8.99B−46%
- Jpmorgan Chase & Co−$10.09B−35%
- Apple−$10.81B−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |